Last reviewed · How we verify
Application of T-lymphocytes
Application of T-lymphocytes targets the immune system
Application of T-lymphocytes targets the immune system Used for Treatment of various cancers.
At a glance
| Generic name | Application of T-lymphocytes |
|---|---|
| Sponsor | Hannover Medical School |
| Drug class | Immunotherapy |
| Target | T-lymphocytes |
| Modality | Small molecule |
| Therapeutic area | Immunology |
| Phase | Phase 2 |
Mechanism of action
T-lymphocytes are a type of immune cell that play a crucial role in the body's defense against infection and disease. By applying T-lymphocytes, the treatment aims to enhance the body's immune response and fight against certain diseases.
Approved indications
- Treatment of various cancers
Common side effects
Key clinical trials
- Immunotherapy Combined With Auto-HSCT and CD22/CD19 CAR-T Sandwich Strategy for B-ALL (PHASE2)
- International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020) (PHASE3)
- Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis (PHASE1, PHASE2)
- Comparative Evaluation of the Safety and Effectiveness of Crisaborole Ointment (2%) Versus Tacrolimus Ointment (0.1%) for the Topical Treatment of Atopic Dermatitis (PHASE4)
- T-cell Therapy in Patients With PML (PHASE2)
- Peptide Vaccine for Fibrolamellar Hepatocellular Carcinoma Patients and Other Tumor Entities Carrying the Driver Fusion DNAJB1-PRKACA (PHASE1)
- SL4903 CAR-T Therapy for Relapsed/Refractory Multiple Myeloma (EARLY_PHASE1)
- Treatment of Mycosis Fungoides With Hypericin Ointment and Visible Light (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Application of T-lymphocytes CI brief — competitive landscape report
- Application of T-lymphocytes updates RSS · CI watch RSS
- Hannover Medical School portfolio CI